IT costs have been significantly reduced! The backlog for desktop support has also been eliminated!
Founded in 2008, Constellation Pharmaceuticals is advancing the development of novel small molecule therapeutics targeting epigenetic mechanisms in tumors and immune cells. At the time of contracting with Arxspan, the internal scientific team and CRO were using electronic lab notebooks (ELN), but the compound registration system and inventory system within Constellation were not linked to the ELN. The company determined that "Arxspan Notebook" would overcome the limitations of the existing client-server ELN and meet both the current and future needs of scientists. Both users and the IT department were satisfied, IT costs were significantly reduced, and there was no backlog in desktop support. [Challenges] - The initial ELN was slow to load, and uploading attachments such as supporting spectral data took a considerable amount of time. - Sign & Close and Witness were also slow. *For more details, please refer to the PDF document or feel free to contact us.*
Inquire About This Product
basic information
【After the Transition】 ■ IT costs have been significantly reduced, and there is no longer a backlog in desktop support. ■ There are almost no "help desk" issues for 60 to 70 users, and Arxspan is handling them in a visible manner for users. ■ There were some areas that required adjustments initially, such as calculations for the chemistry grid, but we were able to respond quickly. *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs![[Case Study] Transition to Cloud-Based Electronic Lab Notebook](https://image.mono.ipros.com/public/catalog/image/01/cff/681776/IPROS09838909133644153473.jpeg?w=120&h=170)
Company information
Bruker Biospin Group designs, manufactures, and sells instruments based on magnetic resonance technology, including world-class nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectrometers. They also develop preclinical imaging systems with single and multiple modes using magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), computed tomography (CT), and magnetic particle imaging (MPI) technologies. Bruker Biospin provides the unique capabilities of NMR to determine the structure, dynamics, and functions of specific molecules to customers in academic research institutions, government agencies, industry, and pharmaceutical companies. In particular, applications in structural proteomics, drug discovery, pharmaceutical and biotechnology research and production, and food and materials science are expected to be promising.